CN1415361A - Chinese medical preparation for curing cholecystitis - Google Patents
Chinese medical preparation for curing cholecystitis Download PDFInfo
- Publication number
- CN1415361A CN1415361A CN 02144829 CN02144829A CN1415361A CN 1415361 A CN1415361 A CN 1415361A CN 02144829 CN02144829 CN 02144829 CN 02144829 A CN02144829 A CN 02144829A CN 1415361 A CN1415361 A CN 1415361A
- Authority
- CN
- China
- Prior art keywords
- cholecystitis
- chinese medicine
- myrrha
- olibanum
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating cholecystitis is prepared from 10 Chinese-medicinal materials including frankincense, myrrh, trichosanthes root, arctium fruit, etc. Its advantages are high curative effect, no toxic by-effect, short course of treatment and no recurrence.
Description
Technical field:
The present invention relates to treat the medicine of cholecystitis, is a kind of Chinese medicine preparation for the treatment of cholecystitis, belongs to the Chinese medicine and pharmacy technical field.
Background technology:
At present, conventional cholecystitis medicine has a lot, but treatment cycle, medical expense and user's rule have difference greatly, and the tangible drug price of curative effect has increased patient's financial burden than higher; Adopt common Drug therapy, clinical symptom disappearance is not obvious, and drug side effect is big, and treatment cycle is long, has aggravated patient's misery again.
Summary of the invention:
The invention provides a kind of Chinese medicine preparation for the treatment of cholecystitis, have low price, evident in efficacy, toxic and side effects is little, characteristics such as treatment cycle is short.
The present invention is the Therapeutic Principle according to motherland's traditional Chinese medical science traditional theory to the pathogenesis of cholecystitis disease, in conjunction with the modern medicine achievement, selected pure Chinese herbal medicine with functions such as anti-inflammatory analgetic, removing damp-heat, activating blood circulation to dissipate blood stasis, dredge the meridian passage, make pharmaceutical preparation through science, be used to remove the pathogenesis of cholecystitis, thoroughly diminish inflammation.
Medicine of the present invention is the Chinese medicine preparation of being made by following component (by ratio of weight and the number of copies):
Olibanum 15~30, Myrrha 15~20, Radix Trichosanthis 10~20, Cortex Lycii 10~20,
Fructus Arctii 15~18, Concha Ostreae 12~25, the Radix Angelicae Dahuricae 12~25, Fructus Forsythiae 15~20,
Caulis Akebiae 3~10, Semen Pittospori Glabrati 8~15.
Optimum ratio of the present invention is (ratio of weight and number):
Olibanum 20, Myrrha 15, Radix Trichosanthis 12, Cortex Lycii 12, Fructus Arctii 15, Concha Ostreae 12,
The Radix Angelicae Dahuricae 15, Fructus Forsythiae 15, Caulis Akebiae 5, Semen Pittospori Glabrati 10.
Processing procedure of the present invention is as follows: take by weighing said medicine in proportion, half fine powder that is ground into about 80 orders wherein is stand-by, four times of water gagings of another false add decoct twice, and each 2 hours, collecting decoction, filter, filtrate is concentrated into relative density 1.20~1.25 (80~85 ℃), and with above-mentioned fine powder mix homogeneously, xeraphium becomes fine powder, with 60% ethanol is that wetting agent is made granule, drying, granulate, sterilization packaging.
Also can directly said medicine be taken by weighing in proportion, be ground into the fine powder about 80 orders, incapsulate and get final product through 100~110 ℃ of high-temperature maturings, sterilization.
Above-mentioned medicament can be a said dosage form on any pharmaceutics.
The combination principle of preparation of the present invention: with Olibanum, Myrrha, Radix Trichosanthis is principal agent, anti-inflammatory analgetic, water flowing function of gallbladder promoting, and assistant is with Cortex Lycii, Fructus Arctii, Concha Ostreae, the Radix Angelicae Dahuricae, the cool liver of Fructus Forsythiae removing heat from blood, and it is eliminating evil to detoxify; Compatibility Caulis Akebiae, Semen Pittospori Glabrati are used for strengthening the spleen and nourishing the stomach, thick intestinal, beneficial vim and vigour, antiviral so that the poison of dispelling evil in outside.
Usage and consumption: oral; Formulation rate can be according to variations such as route of administration, patient age, body weight, disease type and the orders of severity, and daily dose is 10~16 grams; Each 5~7g, takes with eliminating cold for resuscitation water or yellow wine and to take after mixing it with water at every day three times.
Indication comprises cholecystitis, appendicitis.
Good effect of the present invention is: pure Chinese medicinal preparation, and toxic and side effects is little, and clinical symptom disappearance is rapid, and treating both the principal and secondary aspects of a disease is evident in efficacy, and treatment cycle is short, and low price is cured the no rebound phenomena in back.
Further specify curative effect of the present invention with regard to clinical effectiveness of the present invention below: cholecystitis is long-term exopathogen retardance, coagulation of QI-blood, the disease that Liver and kidney two void cause.
Treatment criterion:
Clinical recovery---symptom complete obiteration, functional rehabilitation is normal, and main physico-chemical examination index is normal.
Produce effects---cardinal symptom disappears, and function is recovered substantially, and main physico-chemical examination index is normal substantially.
Effectively---cardinal symptom disappears substantially, and main physical and chemical index makes moderate progress.
Invalid---with the treatment before compare, each side does not all have improvement.
Clinical statistics is used the T statistical theory and 30 routine cholecystitis patients is treated 11 examples of fully recovering (37%), produce effects 9 examples (30%), effective 7 examples (23%), invalid 3 examples (10%).
The specific embodiment:
Embodiment 1
Take by weighing Olibanum 20kg, Myrrha 15kg, Radix Trichosanthis 12kg, Cortex Lycii 12kg, Fructus Arctii 15kg, Concha Ostreae 12kg, Radix Angelicae Dahuricae 15kg, Fructus Forsythiae 15kg, Caulis Akebiae 5kg, Semen Pittospori Glabrati 10kg remove impurity.Half fine powder that is ground into about 80 orders wherein is stand-by, four times of water gagings of another false add decoct twice, each 2 hours, collecting decoction filters, and filtrate is concentrated into relative density 1.20~1.25 (80~85 ℃), with above-mentioned fine powder mix homogeneously, xeraphium becomes fine powder, is that wetting agent is made granule with 60% ethanol, drying, granulate, sterilization packaging.
Embodiment 2
Take by weighing Olibanum 30kg, Myrrha 20kg, Radix Trichosanthis 15kg, Cortex Lycii 15kg, Fructus Arctii 15kg, Concha Ostreae 20kg, Radix Angelicae Dahuricae 20kg, Fructus Forsythiae 15kg, Caulis Akebiae 10kg, Semen Pittospori Glabrati 10kg, remove impurity, pulverize separately becomes the fine powder about 80 orders, mix homogeneously, through 110 ℃ of high-temperature maturings, sterilization, the fill capsule is made patent medicine.
Claims (3)
1, a kind of Chinese medicine preparation for the treatment of cholecystitis is characterized in that it being the medicine of being made by ratio of weight and the number of copies by following material:
Olibanum 15~30, Myrrha 15~20, Radix Trichosanthis 10~20, Cortex Lycii 10~20,
Fructus Arctii 15~18, Concha Ostreae 12~25, the Radix Angelicae Dahuricae 12~25, Fructus Forsythiae 15~20,
Caulis Akebiae 3~10, Semen Pittospori Glabrati 8~15.
2, Chinese medicine preparation according to claim 1, its optimum ratio are (ratio of weight and number):
Olibanum 20, Myrrha 15, Radix Trichosanthis 12, Cortex Lycii 12, Fructus Arctii 15, Concha Ostreae 12,
The Radix Angelicae Dahuricae 15, Fructus Forsythiae 15, Caulis Akebiae 5, Semen Pittospori Glabrati 10.
3,, it is characterized in that said medicament is a said dosage form on any pharmaceutics according to claim 1,2 described Chinese medicine preparation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02144829 CN1415361A (en) | 2002-11-15 | 2002-11-15 | Chinese medical preparation for curing cholecystitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02144829 CN1415361A (en) | 2002-11-15 | 2002-11-15 | Chinese medical preparation for curing cholecystitis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1415361A true CN1415361A (en) | 2003-05-07 |
Family
ID=4750678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02144829 Pending CN1415361A (en) | 2002-11-15 | 2002-11-15 | Chinese medical preparation for curing cholecystitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1415361A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101940631A (en) * | 2010-09-20 | 2011-01-12 | 贵州弘康药业有限公司 | Method for preparing pollen itching-dispelling pain-relieving tincture |
-
2002
- 2002-11-15 CN CN 02144829 patent/CN1415361A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101940631A (en) * | 2010-09-20 | 2011-01-12 | 贵州弘康药业有限公司 | Method for preparing pollen itching-dispelling pain-relieving tincture |
CN101940631B (en) * | 2010-09-20 | 2012-08-29 | 贵州弘康药业有限公司 | Method for preparing pollen itching-dispelling pain-relieving tincture |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101066303A (en) | Medicine for treating cerebral thrombus, cerebral angiosclerosis, apoplexy and hemiplegia and its prepn | |
CN102872411B (en) | Traditional Chinese medicine composition for treating jaundice | |
CN101590168B (en) | Traditional Chinese medicine combination for treating gout and preparation method thereof | |
CN1317021C (en) | Chinese medicinal formulation for stopping pain for removing Bi | |
CN1173726C (en) | Medicine for curing malignant turnor and its preparation method | |
CN100386106C (en) | Medicine for treating acne and its preparation | |
CN101590166B (en) | Traditional Chinese medicine combination for treating gout and preparation method thereof | |
CN100579544C (en) | Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof | |
CN1067571C (en) | Chinese medicine capsule for treating lumbar and cervical protrusion | |
CN1415361A (en) | Chinese medical preparation for curing cholecystitis | |
CN1056301C (en) | 'Lanweiling' oral liquid for treating appendicitis | |
CN1301122C (en) | Bone strengthening granule of tortoise plastron and astragalus root | |
CN1709477A (en) | Chinese medicine formulation for treating ance disease | |
CN114984160B (en) | Mongolian medicine for treating alcoholic liver disease | |
CN100484559C (en) | Chinese medicine preparation for treating acute and chronic appendicitis | |
CN1088592C (en) | Medicine for treating peptic ulcer | |
CN1168472C (en) | Chinese medicine prepn for treating lupus erythematosus | |
CN1168473C (en) | Chinese medicine prepn for treating arterioscleriosis | |
CN1813876A (en) | Xian Pengliaofu oral preparation-a Chinese medicine for treating bone disease | |
CN1238001C (en) | Medicine for treating diseases of liver, gallbladder and spleen | |
CN106668764A (en) | Formula of traditional Chinese medicine for treating hepatitis and preparation method thereof | |
CN1113667C (en) | Medicine for treating rheumatic and rheumatoid diseases | |
CN1386531A (en) | Chinese medicine for treating syringomyelia | |
CN1091011A (en) | A kind of lithodialysis Chinese traditional medicines depressing lipid electuary and manufacture method | |
CN1318402A (en) | Medicine for traumatic fracture pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
AD01 | Patent right deemed abandoned | ||
C20 | Patent right or utility model deemed to be abandoned or is abandoned |